Clinical Trial Update: Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated subcutaneously administered C1 esterase inhibitor for prevention of angioedema attacks in adolescents and adults with hereditary angio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• C1-esterase inhibitor

Snippet

Sponsor: Shire | Conditions: Hereditary Angioedema (HAE) | Phase 3 | Status: COMPLETED | Results posted: 2018-11-28